Market News & Analysis
FTSE struggles in the face of spreading coronavirus
Fiona Cincotta February 21, 2020 10:58 PM
Euro bounces on PMI data
Ironically, before the virus, Europe may have been on the cusp of improvement. The region’s purchasing managers index hit a 12 month high of 49.1 this month, up from 47.9 in January, in a development that might have been caused by changes to the supply chain after some Chinese factories closed down in January. Next month’s reading is unlikely to show the same kind of improvements given that the German economy, the region’s largest, is heavily exposed to China, particularly in the car and parts industry. Still, the euro perked up after the unexpectedly positive PMI data, trading up 0.30% against the dollar but nearly flat against the pound.
EU meets to consider budget after Brexit
And sterling and Britain would have been among the talking points for EU heads of states last night while they were discussing the bloc’s next joint budget and how to plug the whole in financing left by Brexit. Frictions are high as member states are in a deadlock over who should contribute more and what the new budget, which is due to be published today, should be spent on: the environment, immigration or farm aid.
Virus drags commodity firms and miners lower
On the FTSE Pearson was the hardest hit stock after the firm reported a 50% drop in operating profit and then followed this up with a profit warning for 2020. Commodity companies, miners, luxury goods group Burberry and hotel chains continue to carry the burden of the infection in Asia and are all trading lower. A global airlines trade group now estimates that COVID-19 will cost the industry around $29 billion in lost revenue.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.